Last edition
News about "Onswik Type 2 Diabetes treatment"
UK MHRA Approves Onswik Insulin for Adults With Type 2 Diabetes
The UK MHRA has authorised Onswik (insulin efsitora alfa), a once-weekly insulin treatment for adults with Type 2 Diabetes, potentially reducing injections to 52 a year.
Onswik Type 2 Diabetes Treatment | 15/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members